O

    Ocugen Inc (OCGN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.33
    +0.01 (+0.76%)

    Market Cap: $447.63M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    45%(18/40)
    Avg Surprise
    -33.44%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.05
    Range$-0.07 - $-0.04
    3 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$-0.05+6.2%
    60d ago$-0.05+0.0%
    30d ago$-0.05+0.0%
    7d ago$-0.05+0.0%
    Current$-0.05
    Revenue Consensus
    $898000
    Range$0 - $2M
    6 analysts
    Dec 31, 2026
    EPS Consensus$-0.11
    Range$-0.12 - $-0.10
    2 analysts
    Revenue Consensus
    $3M
    Range$876030 - $4M
    6 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.11---
    Sep 26EST
    		-$-0.05---
    Jun 26
    		$-0.07$-0.05-40.00%Miss-40.0%
    Mar 26
    		$-0.06$-0.05-20.00%Miss-20.0%
    Dec 25
    		$-0.06$-0.06-7.14%Miss-20.0%
    Sep 25
    		$-0.07$-0.06-16.67%Miss-40.0%
    Jun 25
    		$-0.05$-0.06+16.67%Beat-25.0%
    Mar 25
    		$-0.05$-0.06+16.67%Beat+0.0%
    Dec 24
    		$-0.05$-0.05+6.19%Beat-66.7%
    Sep 24
    		$-0.05$-0.05+0.00%Beat+16.7%
    Jun 24
    		$-0.04$-0.05+20.00%Beat+60.0%
    Mar 24
    		$-0.05$-0.06+16.67%Beat+28.6%
    Dec 23
    		$-0.03$-0.06+50.00%Beat+70.0%
    Sep 23
    		$-0.06$-0.07+14.29%Beat+40.0%
    Jun 23
    		$-0.10$-0.07-42.86%Miss-11.1%
    Mar 23
    		$-0.07$-0.11+36.36%Beat+22.2%
    Dec 22
    		$-0.10$-0.10+0.00%Beat-42.9%
    Sep 22
    		$-0.10$-0.10+0.00%Beat-100.0%
    Jun 22
    		$-0.09$-0.08-12.50%Miss+30.8%
    Mar 22
    		$-0.09$0.01-776.69%Miss-125.0%
    Dec 21
    		$-0.07$-0.07+0.00%Beat-133.3%
    Sep 21
    		$-0.05$-0.04-25.00%Miss+28.6%
    Jun 21
    		$-0.13$-0.03-333.33%Miss+31.6%
    Mar 21
    		$-0.04N/A-110.00%Miss+42.9%
    Dec 20
    		$-0.03$-0.02-50.00%Miss-100.7%
    Sep 20
    		$-0.07$-0.02-250.00%Miss+98.0%
    Jun 20
    		$-0.19$-0.04-375.00%Miss-58.3%
    Mar 20
    		$-0.07$-0.05-40.00%Miss+98.5%
    Dec 19
    		$4.13$-0.14+3050.00%Beat+162.6%
    Sep 19
    		$-3.55$-0.60-491.67%Miss+75.3%
    Jun 19
    		$-0.12$-0.01-1100.00%Miss+98.5%
    Mar 19
    		$-4.80$-0.60-700.00%Miss+84.6%
    Dec 18
    		$-6.60$-3.60-83.33%Miss+57.7%
    Sep 18
    		$-14.40$-12.20-18.03%Miss-4.3%
    Jun 18
    		$-7.80$-14.00+44.29%Beat+48.0%
    Mar 18
    		$-31.20$-13.20-136.36%Miss-92.6%
    Dec 17
    		$-15.60$-16.20+3.70%Beat+58.1%
    Sep 17
    		$-13.80$-16.92+18.44%Beat+54.9%
    Jun 17
    		$-15.00$-18.15+17.36%Beat-
    Mar 17
    		$-16.20$-20.70+21.74%Beat-
    Dec 16
    		$-37.20$-27.00-37.78%Miss-
    Sep 16
    		$-30.60$-29.55-3.55%Miss-

    Key Metrics

    Valuation
    P/E Ratio-5.12EV/EBITDA-1.95x
    Price/FCF-7.38xFCF Yield-13.55%
    Profitability
    Profit Margin0.00%Operating Margin-1105.00%
    ROE-660.00%ROIC385.96%
    Financial Health
    Debt/Equity-0.11xInterest Coverage-7.22x
    Current Ratio0.80xQuick Ratio0.80x
    Trading Statistics
    Beta2.20Avg Volume3.87M
    52-Week High$2.7352-Week Low$1.00

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.38
    SMA 20$1.35
    SMA 50$1.37
    SMA 200$1.51
    EMA 10$1.36
    EMA 20$1.36
    EMA 50$1.37
    EMA 200$1.42

    MACD

    Line: 0.01Signal: 0.01Hist: -0.00

    ADX

    ADX: 13.9+DI: 18.1-DI: 22.9

    Aroon & PSAR

    Aroon Up68.0
    Aroon Down8.0
    PSAR$1.47

    Bollinger Bands

    Upper Band$1.46
    Lower Band$1.24
    %B Position1614%(Upper)
    Band Width0.40

    RSI (14-Day)

    Neutral
    47.7

    Momentum Oscillators

    Stoch %K27.4
    Stoch %D43.3
    Williams %R-76.2
    ROC (10d)-3.3%
    Momentum-0.04
    CCI (20d)-56.0
    MFI (14d)40.3

    Volatility Measures

    ATR (14d)$0.07(5.3%)
    StdDev (20d)0.05
    Hist Vol61.1%(High)

    Volume Flow

    VWAP$1.32
    OBV60.9M
    AD Line-197.1M
    CMF (20d)0.054

    Volume Metrics

    Avg Vol (20d)3.9M
    Vol Ratio1.2x
    VWMA (20d)$1.35

    Pivot Points

    R3$1.40
    R2$1.39
    R1$1.35
    Pivot Point$1.34
    S1$1.30
    S2$1.29
    S3$1.25

    Advanced Oscillators

    TSI2.78
    Ultimate Osc46.3
    KST31.60

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$1.49M$1.53M$-193,000$1.75M$1.37M$1.48M$764,000$1.14M$1.14M$1.01M$1.41M$3.70M
    Cost of Revenue$0$0N/A$0$0$0$598,000$0$0$0$179,000$0
    Gross Profit$1.49M$1.53M$-193,000$1.75M$1.37M$1.48M$764,000$1.14M$1.14M$1.01M$1.41M$3.70M
    Operating Expenses$17.93M$19.37M$16.80M$19.38M$15.17M$15.98M$14.60M$14.39M$16.59M$13.23M$12.93M$16.13M
    R&D$10.69M$11.26M$10.67M$11.15M$8.40M$9.53M$8.29M$8.11M$8.90M$6.83M$7.78M$7.05M
    SG&A$7.24M$8.12M$6.13M$8.23M$6.77M$6.45M$6.31M$6.28M$7.69M$6.40M$5.16M$9.08M
    Operating Income$-16,444,000$-17,839,000$-16,995,000$-17,625,000$-13,795,000$-14,501,000$-13,840,000$-13,252,000$-15,449,000$-12,216,000$-11,525,000$-12,431,000
    Interest Income$395,000$132,000$2.69M$207,000$227,000$343,000$466,000$310,000$173,000$302,000$0$0
    Interest Expense$6.86M$1.32M$532,000$1.31M$1.28M$1.26M$54,000$29,000$0$0$0$0
    Income Before Tax$-24,877,000$-19,177,000$-17,527,000$-20,051,000$-14,739,000$-15,350,000$-13,894,000$-12,970,000$-15,276,000$-11,914,000$-11,525,000$-12,431,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-24,877,000$-19,177,000$-17,706,000$-20,051,000$-14,739,000$-15,350,000$-13,880,000$-12,970,000$-15,280,000$-11,924,000$-10,970,000$-11,717,000
    EBITDA$-15,911,000$-17,022,000$-17,392,000$-17,994,000$-12,754,000$-13,527,000$-13,242,000$-12,638,000$-14,871,000$-12,037,000$-11,346,000$-12,254,000
    EBIT$-18,413,000$-17,989,000$-16,995,000$-18,944,000$-13,681,000$-14,436,000$-13,840,000$-13,251,000$-15,449,000$-12,216,000$-11,525,000$-12,431,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about OCGN

    News

    Ocugen to Participate in Upcoming September Investor and Industry Conferences

    Ocugen, Inc. announced its participation in three upcoming September 2026 events: the Citi 2026 Biopharma Back to School Conference, the H.C. Wainwright 28th Annual Global Investment Conference, and The Retina Society 59th Annual Scientific Meeting. Dr. Shankar Musunuri will present on Ocugen's modifier gene therapy platform at the investor conferences, while Dr. Raj K. Maturi will present on the OCU410 gene therapy for geographic atrophy at The Retina Society meeting. Webcasts of the investor conference presentations will be available on Ocugen's website.

    The Manila Times•8/25/26•
    Somewhat-Bullish

    Ocugen Inc. stock falls Monday, underperforms market

    Ocugen Inc. (OCGN) shares fell by 2.16% on Monday, closing at $1.36. This performance put the company 50.09% below its 52-week high, despite a mixed trading session where the Dow Jones Industrial Average rose and the S&P 500 Index declined.

    MarketWatch•8/24/26•
    Bearish

    Ocugen | SCHEDULE 13G: Others

    This document, titled "Ocugen | SCHEDULE 13G: Others," likely contains information regarding beneficial ownership of Ocugen stock, as required by SEC Schedule 13G filings. Schedule 13G is a short-form statement for passive investors who own more than 5% of a company's stock, indicating that the filing is from a non-activist shareholder.

    Moomoo•8/23/26•
    Neutral

    Ocugen | DEFA14A: Others

    This article is a DEFA14A filing by Ocugen, indicating the company has submitted a definitive additional soliciting material to the SEC. The content of the filing itself is not provided in the snippet, but it typically relates to proxy solicitations and shareholder meetings.

    Moomoo•8/22/26•
    Neutral

    Ocugen (OCGN) Reports Q1 Loss, Beats Revenue Estimates

    Ocugen (OCGN) reported a Q1 loss of $0.06 per share, slightly wider than the Zacks Consensus Estimate of a $0.05 loss, representing an earnings surprise of -12.57%. However, the company surpassed revenue estimates, posting $1.53 million for the quarter, which was 27.75% above the consensus. Ocugen shares have increased by 37% year-to-date, outperforming the S&P 500's 5.2% gain, and currently hold a Zacks Rank #3 (Hold).

    Eastern Progress•8/22/26•
    Neutral

    Frequently Asked Questions About OCGN

    Does OCGN pay dividends?
    Ocugen Inc (OCGN) does not currently pay a regular dividend.
    What is OCGN's market cap?
    Ocugen Inc (OCGN) has a market capitalization of $447.63M with a current stock price of $1.33.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In